As the global HIV response faces rising risks, UNAIDS shifts to a leaner, sharper model focused on country impact . GENEVA, 10 May 2025—In the face of continued high numbers of ...

Modern HIV medicine is based on a common genetic mutation. Now, researchers have traced where and when the mutation arose -- and how it protected our ancestors from ancient diseases.

Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.

The HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.

A panelist discusses how the new doravirine and islatravir combination offers an alternative to integrase inhibitor-based ...

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe.

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

A disruption in federal funds has jeopardized HIV testing and outreach in the U.S. South, and researchers warn of a ...

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

It’s estimated that over 10 million people around the world develop Alzheimer’s disease annually,” said UVA Health researcher Jayakrishna Ambati, MD. “Our results suggest that taking these drugs could ...

To date, USAID has distributed more than $40bn a year of aid, including HIV programmes under Pepfar (President’s Emergency Plan for AIDS Relief). As of 2023, more than 25 million lives have been ...